Clusterin as a New Marker of Kidney Injury in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation-A Pilot Study.
Kinga MusiałMonika AugustynowiczIzabella Miśkiewicz-MigońKrzyzstof KalwakMarek UssowiczDanuta ZwolińskaPublished in: Journal of clinical medicine (2020)
The features of kidney injury are present even before alloHSCT. Clusterin seems useful in the assessment of subclinical AKI and may become a new early marker of sublethal kidney injury in children.